Akagera Medicines, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Akagera Medicines, Inc.
Quantité totale PI 25
Rang # Quantité totale PI 59 423
Note d'activité PI 2,4/5.0    32
Rang # Activité PI 23 741

Brevets

Marques

14 0
4 0
7 0
0
 
Dernier brevet 2025 - Lipid nanoparticles for delivery...
Premier brevet 2021 - Oxazolidinone compounds, liposom...

Derniers inventions, produits et services

2024 Invention Lipid nanoparticles for delivery of nucleic acids and methods of use thereof. The present disclos...
Invention Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of u...
Invention Lipid nanoparticles for delivery of nucleic acids and methods of use thereof. The present disclo...
Invention Ionizable cationic lipids. The present disclosure provides compounds useful as ionizable cationi...
2023 Invention Lipid nanoparticles for the prevention of tuberculosis or other mycobacterial infections. Aspects...
Invention Lipid nanoparticles for delivery of nucleic acids and vaccine for the prevention of coronavirus i...
2022 Invention Oxazolidinone liposome compositions. Aspects of the disclosure relate to various liposomal compo...
Invention Oxazolidinone liposome compositions. Aspects of the disclosure relate to various liposomal compos...
Invention Ionizable cationic lipids. The present disclosure provides compounds useful as ionizable cationic...
2021 Invention Lipid nanoparticles for delivery of nucleic acids, and related methods of use. in vivoin vivo. In...
Invention Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of ...